Peer Review History
| Original SubmissionMarch 1, 2024 |
|---|
|
PONE-D-24-08404Functional regression clustering with multiple functional gene expressionsPLOS ONE Dear Dr. Ezer, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jul 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ruofei Du, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please expand the acronym “EPSRC and BBSRC” (as indicated in your financial disclosure) so that it states the name of your funders in full. This information should be included in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: "This project was funded by the Alan Turing Institute Research Fellowship under EPSRC Research grant (TU/A/000017) to DE; SRC/BBSRC Innovation Fellowship (EP/S001360/1) to DE and SC. ST would like o thank the Isaac Newton Institute for Mathematical Sciences, Cambridge, for support and hospitality during the programme Statistical Scalability where work on this paper was undertaken. This work was supported by EPSRC grant no EP/R014604/1." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This project was funded by the Alan Turing Institute Research Fellowship under EPSRC Research grant (TU/A/000017) to DE; EPSRC/BBSRC Innovation Fellowship (EP/S001360/1) to DE and SC. ST would like to thank the Isaac Newton Institute for Mathematical Sciences, Cambridge, for support and hospitality during the programme Statistical Scalability where work on this paper was undertaken. This work was supported by EPSRC grant no EP/R014604/1. Engineering and Physical Sciences Research Council (EPSRC): https://www.ukri.org/councils/epsrc/ Alan Turing Institute: https://www.turing.ac.uk/ Biotechnology and Biological Sciences Research Council (BBSRC): https://www.ukri.org/councils/bbsrc/ Isaac Newton Institute for Mathematical Sciences: https://www.newton.ac.uk/ The funders did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 4. We notice that your supplementary figures are uploaded with the file type 'Figure'. Please amend the file type to 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. Additional Editor Comments: The authors please be aware of an inconsistency regarding the corresponding author's name. In the submission process, the corresponding author is identified as Daphne Ezer, but elsewhere, including in the cover letter and the manuscript, the corresponding author is identified as Susana Conde. Please help straighten this out. I tried to access the R code mentioned in the manuscript at https://gitlab.com/sconde778/frmm_rpackagefunctions.git. However, I was prompted to create a personal account and then encountered a 404 page. If possible, please save your R code in an easily accessible web repository, such as GitHub. Ensure your code sharing is functional to facilitate the review process moving forward smoothly. Please also be aware that one of the reviewer's comments is provided in an attachment. If you cannot see it, please contact PLOS ONE for assistance. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Review of “Functional regression clustering with multiple functional gene expressions” Summary This manuscript presents a novel clustering method, functional regression clustering (FRECL), for analyzing temporal gene expression profiles. FRECL utilizes a concurrent functional linear regression model and is inspired by the traditional K-means clustering algorithm. Focusing on the associations between response and explanatory variables, the method updates each gene’s cluster label based on the best-fitted functional regression model with the smallest residual norm, aiming to identify groups of differentially expressed genes linked to biological processes over time. By treating temporal gene expression observations as functions, FRECL effectively groups genes with varying temporal expression profiles under different conditions while capturing similar changes across treatments. This approach provides a new tool for understanding gene expression dynamics and their biological implications. The authors did a good job investigating algorithm properties, i.e., the effect of the number of clusters, sample size, sensitivity study, convergence, etc. However, I hope some major and minor concerns can be addressed. Major comments In Line 89, the manuscript discusses the extension to settings with distinct domains for the response and each predictor. It would be better if the discussion section re-commented on this possible extension to different domains. In Line 105, equation (4). It would be clearer if math notations were used to explain Y and functional parameters beta. Also, the Phi function used in equation (4) might be different from the equation above. A different notation for better explanations should be considered. In Lines 263-265, L1 and L2 norms are mentioned in (iv). Although the results can be put into the supplementary material, a discussion about L1 and L2 norms is still meaningful in the main text. Related to the above comments, in the main text simulation results display, the L2 norm was automatically chosen for every sub-section. It would be better to state why only the L2 norm is used in other simulation comparisons. In the “Comparison with other methods” section, it will also be interesting to see the performance of other competing methods (considering observations formed with the values of both the explanatory and response variables) in the simulation study, not only based on response variable Y. It is interesting to investigate the convergence properties of FRECL under the IID random error. A different (might be early) convergence rate might be expected. Minor comments Line 54, the expectation of error should have brackets. Lines 89 and 90, “our methods” and “each predictor” should be “our method” and “each predictor”. Line 119, you used a new notation, k ̂(i). An explanation or definition is expected in lines 123 and 124 for easier understanding. Line 208, the “5) in 20” expression for the threshold of filtering lowly expressed genes is confusing. Line 212, “loess” is short for Locally estimated scatterplot smoothing, which should be capitalized. Also, the approach’s full name should be stated the first time it is used in the manuscript. Figure 5 caption, please define or clarify the definition of “final ARI”. The arrangement of Figure 7 could be improved to enhance clarity. It would be better to use A, B, C, and D letters for the top left, top right, bottom left, and bottom right to point out each sub-figure. The current layout is confusing. Reviewer #2: The manuscript presents a significant contribution to the field of gene expression analysis through a novel clustering method. By addressing the comments and suggestions provided, the authors can enhance the clarity, readability, and overall impact of their work. The method's robustness, supported by comprehensive validation and practical application, underscores its potential for advancing biological insights in gene expression studies. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Xinmin Chu ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
Functional regression clustering with multiple functional gene expressions PONE-D-24-08404R1 Dear Dr. Ezer, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ruofei Du, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Please pay attention to a few of minor suggestions from the reviewers. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: line 115 in Revised Manuscript with Track changes: the expectation of error should have parentheses. Reviewer #2: The revised manuscript is reasonable and clear. The authors showed details on parameter selection, discussion on computational efficiency, and expansion with recent work that highlights the significance of the biological pathways. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Xinmin Chu ********** |
| Formally Accepted |
|
PONE-D-24-08404R1 PLOS ONE Dear Dr. Ezer, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ruofei Du Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .